Brought to you by 
PainCeptor closes $17.3mm Series A round
04 Apr 2004
Executive Summary
PainCeptor Pharma (developing drugs to treat acute and chronic pain) raised $17.3mm ($Cdn23mm) in its Series A financing round led by CDP Capital. Additional investors included the Business Development Bank of Canada, Desjardins Venture Capital, Canadian Medical Discoveries Fund, T2C2/BIO 2000, MDS Capital, and Innovatech.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
PainCeptor closes $17.3mm Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice